Trial Profile
Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens: a Multicentre Randomized Parallel-group Clinical Trial
Status:
Recruiting
Phase of Trial:
Phase 0
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Acarbose (Primary) ; Gliclazide (Primary) ; Insulin aspart/insulin protamine aspart (Primary) ; Insulin glargine (Primary) ; Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 30 Oct 2015 New trial record